Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Diabetes, obesity & metabolism"
topic_facet:"Insulin Glargine"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Insulin+Glargine%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Insulin+Glargine%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Insulin+Glargine%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (44)
1
Ultra-rapid lispro improved postprandial glucose control compared to insulin lispro in predominantly Chinese patients with type 1 diabetes : A prospective, randomized, double-blind phase 3 study
enthalten in:
Diabetes, obesity & metabolism
| 2024
von
Ma, J.
|
Yan, X.
|
Feng, Q.
| +7
Wird geladen...
2
Efficacy and safety of adding once-weekly dulaglutide to basal insulin for inadequately controlled type 2 diabetes in Chinese patients (AWARD-CHN3) : A randomized, double-blind, placebo-controlled, phase III trial
enthalten in:
Diabetes, obesity & metabolism
| 2023
von
Wang, W.
|
Yan, X.
|
Cheng, Z.
| +5
Wird geladen...
3
Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetes
enthalten in:
Diabetes, obesity & metabolism
| 2023
von
Philis-Tsimikas, A.
|
Bajaj, H.
|
Begtrup, K.
| +6
Wird geladen...
4
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11) : A randomized, open-label, multinational, phase 3b trial
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Kellerer, M.
|
Kaltoft, M.
|
Lawson, J.
| +4
Wird geladen...
5
Immunogenicity of LY2963016 insulin glargine and Lantus® insulin glargine in Chinese patients with type 1 or type 2 diabetes mellitus
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Wang, W.
|
Song, X.
|
Lou, Y.
| +3
Wird geladen...
6
Comparable efficacy and safety between LY2963016 insulin glargine and insulin glargine (Lantus®) in Chinese patients with type 1 diabetes : A phase III, randomized, controlled trial
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Yan, X.
|
Jiang, S.
|
Lou, Y.
| +1
Wird geladen...
7
Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes : Design and baseline characteristics of the SoliMix randomized controlled trial
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
McCrimmon, R.
|
Al Sifri, S.
|
Emral, R.
| +11
ErratumIn: Diabetes Obes Metab. 2021 Nov;23(11):2600. - PMID 34463418
Wird geladen...
8
Benefits of the fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide (iGlarLixi) in Japanese people with type 2 diabetes : A subgroup and time-to-control analysis of the LixiLan JP phase 3 trials
enthalten in:
Diabetes, obesity & metabolism
| 2020
von
Terauchi, Y.
|
Yabe, D.
|
Kaneto, H.
| +5
Wird geladen...
9
Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes : A randomized, parallel-design, open-label, Phase 3 trial
enthalten in:
Diabetes, obesity & metabolism
| 2020
von
Vilsbøll, T.
|
Ekholm, E.
|
Johnsson, E.
| +4
Wird geladen...
10
Efficacy and safety of MYL-1501D versus insulin glargine in people with type 1 diabetes mellitus : Results of the INSTRIDE 3 phase 3 switch study
enthalten in:
Diabetes, obesity & metabolism
| 2020
von
Blevins, T.
|
Barve, A.
|
Raiter, Y.
| +4
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Diabetes, obesity & metabolism
Filter aufheben
Thema: Insulin Glargine
Medienart
44
Aufsätze
44
E-Artikel
44
E-Ressourcen
Zeitschriftentitel
Diabetes, obesity & metabolism
Thema
44
2ZM8CX04RZ
44
Clinical Trial, Phase III
Insulin Glargine
44
Journal Article
42
Randomized Controlled Trial
36
Glycated Hemoglobin A
36
Hypoglycemic Agents
33
Research Support, Non-U.S. Gov't
31
Blood Glucose
30
Multicenter Study
25
type 2 diabetes
19
hemoglobin A1c protein, human
17
insulin glargine
14
basal insulin
14
glycaemic control
13
Comparative Study
13
type 1 diabetes
10
Insulin Lispro
10
hypoglycaemia
7
62340-29-8
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
10
2020-
34
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
44
Englisch
Haven't found what you're looking for?
Wird geladen...